drugset / Trial / NCT02609607

Treating Anorectal Dysfunction in MS

NCT02609607

RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators seek to test whether incorporating the scheduled dosing of a bisacodyl 10 mg rectal suppository every other day improves bowel-related symptoms in patients with multiple sclerosis. Patients will be randomized to receive either a placebo suppository or bisacodyl suppository dosed every other day for 4 weeks.

Timeline

Start
2016-06
Primary completion
2018-11
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bisacodyl Small molecule 10 mg Rectal